TCB Self-Monitoring in Healthy Term and Near-Term Neonates
NCT ID: NCT06645158
Last Updated: 2025-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
220950 participants
OBSERVATIONAL
2020-08-01
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants Compare the changing trend of TCB among different areas in China Compare the changing trend of TCB among different gestational groups in China
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants
NCT01763632
Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates
NCT00653874
Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants
NCT03195998
Transcutaneous Bilirubinometry in Neonates
NCT01422655
Prediction of Neonatal Hyperbilirubinemia
NCT01109277
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
normal neonate
gestational age \>= 35wk; did not admitted to hospital for any reason; did not need phototherapy within 60h after birth;
Transcutaneous bilirubin level monitoring
self-monitoring by parents long-term: from birth to 30 days of age
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcutaneous bilirubin level monitoring
self-monitoring by parents long-term: from birth to 30 days of age
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
0 Days
30 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guangzhou Women and Children's Medical Center
OTHER
Neonatal-Infant Brain and Behavior Development Network
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guangzhou Women and Children's Medical Center,
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Multi-TCB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.